SG11202108544XA - Extracellular matrix modulating agent - Google Patents
Extracellular matrix modulating agentInfo
- Publication number
- SG11202108544XA SG11202108544XA SG11202108544XA SG11202108544XA SG11202108544XA SG 11202108544X A SG11202108544X A SG 11202108544XA SG 11202108544X A SG11202108544X A SG 11202108544XA SG 11202108544X A SG11202108544X A SG 11202108544XA SG 11202108544X A SG11202108544X A SG 11202108544XA
- Authority
- SG
- Singapore
- Prior art keywords
- extracellular matrix
- modulating agent
- matrix modulating
- agent
- extracellular
- Prior art date
Links
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 title 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 title 1
- 210000002744 extracellular matrix Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2019/007735 WO2020174638A1 (en) | 2019-02-28 | 2019-02-28 | Extracellular matrix modulating agent |
| JP2019179428 | 2019-09-30 | ||
| PCT/JP2020/008101 WO2020175636A1 (en) | 2019-02-28 | 2020-02-27 | Extracellular matrix modulating agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202108544XA true SG11202108544XA (en) | 2021-09-29 |
Family
ID=72238500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202108544XA SG11202108544XA (en) | 2019-02-28 | 2020-02-27 | Extracellular matrix modulating agent |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220133714A1 (en) |
| EP (1) | EP3930844A4 (en) |
| JP (1) | JP2022529871A (en) |
| KR (1) | KR20210139225A (en) |
| CN (1) | CN113631226A (en) |
| BR (1) | BR112021015873A2 (en) |
| CA (1) | CA3129856A1 (en) |
| MX (1) | MX2021009751A (en) |
| SG (1) | SG11202108544XA (en) |
| TW (1) | TW202045186A (en) |
| WO (1) | WO2020175636A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4168071B2 (en) * | 2005-12-08 | 2008-10-22 | 興和株式会社 | Ophthalmic composition |
| KR102432692B1 (en) * | 2014-09-24 | 2022-08-12 | 교와 가부시키가이샤 | Corneal thickness adjustment agent |
-
2020
- 2020-02-20 TW TW109105395A patent/TW202045186A/en unknown
- 2020-02-27 US US17/430,068 patent/US20220133714A1/en active Pending
- 2020-02-27 EP EP20763778.6A patent/EP3930844A4/en active Pending
- 2020-02-27 CA CA3129856A patent/CA3129856A1/en active Pending
- 2020-02-27 MX MX2021009751A patent/MX2021009751A/en unknown
- 2020-02-27 WO PCT/JP2020/008101 patent/WO2020175636A1/en unknown
- 2020-02-27 BR BR112021015873A patent/BR112021015873A2/en unknown
- 2020-02-27 SG SG11202108544XA patent/SG11202108544XA/en unknown
- 2020-02-27 CN CN202080014718.XA patent/CN113631226A/en active Pending
- 2020-02-27 JP JP2021544418A patent/JP2022529871A/en active Pending
- 2020-02-27 KR KR1020217025902A patent/KR20210139225A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20220133714A1 (en) | 2022-05-05 |
| TW202045186A (en) | 2020-12-16 |
| CN113631226A (en) | 2021-11-09 |
| CA3129856A1 (en) | 2020-09-03 |
| MX2021009751A (en) | 2021-11-17 |
| KR20210139225A (en) | 2021-11-22 |
| EP3930844A1 (en) | 2022-01-05 |
| WO2020175636A1 (en) | 2020-09-03 |
| JP2022529871A (en) | 2022-06-27 |
| EP3930844A4 (en) | 2022-12-07 |
| BR112021015873A2 (en) | 2021-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL292156A (en) | Substituted azacyles as trmp8 modulators | |
| SI3743406T1 (en) | Tmem16a modulators | |
| EP3402876A4 (en) | Vascular extracellular matrix hydrogel | |
| GB2576056B (en) | Modulators | |
| PT3303291T (en) | Ror gamma (ror ) modulators | |
| EP3186225A4 (en) | Cannabinoid type 1 receptor modulators | |
| GB201716468D0 (en) | Modulators | |
| GB2585803B (en) | Electro-absorption modulator | |
| IL279929A (en) | Oligonucleotides for modulating rtel1 expression | |
| IL276357A (en) | Oligonucleotides for modulating tmem106b expression | |
| ZA202106623B (en) | Virtual agent team | |
| IL289898A (en) | Modulating extracellular matrix movement | |
| GB201913756D0 (en) | Contrast agent | |
| GB2564099B (en) | Electro-Optic Modulator | |
| SG11202108544XA (en) | Extracellular matrix modulating agent | |
| CA209918S (en) | Sprinkler | |
| GB2585587B (en) | Modulators | |
| IL272732A (en) | Activity modulator | |
| GB2563095B (en) | Modulators | |
| EP3570815C0 (en) | Composition for ophthalmic use | |
| GB2589174B (en) | Electro-optic modulator | |
| GB201904793D0 (en) | Extracellular matrix hydrogels | |
| GB2587795B (en) | An electro-optic modulator | |
| GB201903650D0 (en) | Diplay devices | |
| GB202018411D0 (en) | Malt-1 modulators i |